74-1100555 · Houston, TX
TO CREATE A HEALTHIER FUTURE FOR CHILDREN AND WOMEN THROUGHOUT OUR GLOBAL COMMUNITY BY LEADING IN PATIENT CARE, EDUCATION AND RESEARCH.
Total revenue
$3.8B
FY2023
Total expenses
$3.6B
FY2023
Net assets
$5.3B
FY2023
Operating margin
4.8%
NPLens analysis
FY18–FY2023 · from annual filings
Financial health
A
Derived analysis — not an official IRS designation.
Computed from FY2023 · derived analysis
FY2023 · program vs. administration vs. fundraising (Form 990, Part IX)
FY2023 · where revenue comes from (as reported)
Highest-paid officers, directors & key employees · FY2023.
MARK A WALLACE
BOARD MEMBER / CHAIR / PRESIDENT / CEO
$7,669,922
WELDON W GAGE
BOARD MEMBER / EXECUTIVE VICE PRESIDENT / CHIEF FINANCIAL OFFICER
$2,746,652
MYRA L DAVIS
SENIOR VICE PRESIDENT / CHIEF INFORMATION & INNOVATION OFFICER
$2,436,027
MARK W MULLARKEY
BOARD MEMBER & EXECUTIVE VICE PRESIDENT THROUGH 2/24/23
$2,252,417
MICHELLE M RILEY-BROWN
BOARD MEMBER THROUGH 3/31/23 / EXECUTIVE VICE PRESIDENT THROUGH 4/15/23
$2,241,677
Each figure on this page traces to one of these source returns.
Health scores, efficiency ratios, peer percentiles, and outlier flags are derived analysis by NPLens — not official IRS designations. Figures are as reported on the organization's Form 990 filings. How these are computed →